A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors

NCT05110807 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: TQB3617

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.